BAY885

CAS No. 2307249-33-6

BAY885( —— )

Catalog No. M24050 CAS No. 2307249-33-6

BAY885 is a new ERK5 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 168 In Stock
5MG 147 In Stock
10MG 234 In Stock
25MG 424 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BAY885
  • Note
    Research use only, not for human use.
  • Brief Description
    BAY885 is a new ERK5 inhibitor.
  • Description
    BAY885 is a new ERK5 inhibitor.
  • In Vitro
    The ERK5 probe 41 (BAY-885) showed potent ERK5 kinase and transcriptional inhibition in the SN12C-MEF2 reporter cell line (IC50 = 115 nM/IC90 = 691 nM) and had no effects on a reporter control cell line with constitutive luciferase expression (SN12C-CMV-luc, IC50 > 30 μM).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    ERK5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2307249-33-6
  • Formula Weight
    515.53
  • Molecular Formula
    C25H28F3N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:16.67 mg/mL (32.34 mM; Need ultrasonic)
  • SMILES
    CN1CCN(CC1)C2=CC3=C(C(=NC=N3)C4CCN(CC4)C(=O)C5=C(C=C(C=C5)OC(F)(F)F)N)N=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nguyen D, et al. Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5. J Med Chem. 2019 Jan 24;62(2):928-940.
molnova catalog
related products
  • Ulixertinib hydrochl...

    Ulixertinib hydrochloride (Ulixertinib HCl) is an orally available, selective and potent ERK1/2 inhibitor with anticancer and antitumor activity that inhibits the NB cell cycle and promotes apoptosis, and may be used in the study of solid tumors.

  • XMD17-109

    XMD17-109 is a novel, specific ERK-5 inhibitor with an EC50 4.2 uM in HEK293 cells.

  • Tauroursodeoxycholic...

    Tauroursodeoxycholic acid (TUDCA) is a neuroprotective bile conjugate; inhibits nuclear factor-kappa B (NF-κB) activation in glial cells.